ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,689,000 | +2975.1% | 301,621 | +1765.4% | 0.01% | +800.0% |
| Q4 2017 | $185,000 | +0.5% | 16,169 | +7.4% | 0.00% | 0.0% |
| Q3 2017 | $184,000 | -44.6% | 15,060 | +48.8% | 0.00% | -50.0% |
| Q3 2016 | $332,000 | -84.2% | 10,124 | -88.2% | 0.00% | -83.3% |
| Q1 2016 | $2,107,000 | +937.9% | 86,023 | +1289.9% | 0.01% | +1100.0% |
| Q3 2015 | $203,000 | -77.1% | 6,189 | -63.0% | 0.00% | -83.3% |
| Q2 2015 | $885,000 | – | 16,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |